SBIR Phase I: Microbe and Cell Assay (MICA) Device for Measuring Bacteria Antibiotic Susceptibility

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0740008
Agency Tracking Number: 0740008
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2008
Solitcitation Year: N/A
Solitcitation Topic Code: BT
Solitcitation Number: NSF 07-551
Small Business Information
Tribo Flow Separations, LLC
1525 Bull Lea Blvd, Suite 10, Lexington, KY, 40511
Duns: 038094228
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 John Stencel
 PhD
 (859) 259-0011
 john@triboflow.com
Business Contact
 John Stencel
Title: PhD
Phone: (859) 259-0011
Email: john@triboflow.com
Research Institution
N/A
Abstract
This Small Business Innovative Research Phase I project demonstrates the feasibility of a device for rapidly determining the susceptibility of infectious bacteria to antibiotic treatments. Whereas standard susceptibility tests take between 24-96 hours, this device promises to provide assessments in less than two hours without the use of specialized reaction surfaces. To demonstrate feasibility, the real-time activity of bacteria will be monitored during growth in nutrient broths before and after exposure to dosages of simulated antibiotics. Signatures of two distinct bacteria will be followed, minimum measurable concentrations determined, integrative concepts and partnerships for this instrumentation established, and design of a prototype completed. The broader impacts of this research are improved speed and accuracy for diagnosing and treating patients having bacterial infections, decreased costs for patient care at hospitals, emergency departments, physician offices/satellite facilities and point-of-care providers, and heightened automation and ease of operation for a front-line approach that improves health givers' abilities to treat infectious disease and save lives. Furthermore, successful implementation would point to other potential applications in medical, biopharmaceutical and clinical settings.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government